CYP4F2 gene.c.1297G A:Geno:Pt:Bld/Tiss:Nom:Molgen

Preferred Label : CYP4F2 gene.c.1297G A:Geno:Pt:Bld/Tiss:Nom:Molgen;

LOINC status : ACTIVE;

LOINC display name : CYP4F2 gene c.1297G A genotype Molgen (Bld/Tiss);

LOINC long common name : CYP4F2 gene c.1297G A [Genotype] in Blood or Tissue by Molecular genetics method Nominal;

LOINC short name : CYP4F2 c.1297G A Geno Bld/T;

LOINC description : The presence of the CYP4F2*3 (rs2108622) allele indicates that a patient who self-identifies as being of non-African ancestry may require a slightly increased warfarin dose than predicted by CYP2C9/VKORC1 alone.[PMID: 18250228] The rs2108622 variant (c.1297G A) results in an amino acid substitution (valine to methionine) at position 433 (p.V433M).;

Details

Origin ID

93197-2;

UMLS CUI

C5211634;

Has component
- CYP4F2 gene [LOINC component]
- CYP4F2 gene c.1297G>A [LOINC component]
- Gene [LOINC component]
Has method
- Molecular genetics [LOINC method]
Has property
- Genotype [LOINC Property]
Has scale
- Nom [LOINC scale]
Has system
- Blood [LOINC System]
- Blood or Tissue [LOINC System]
- Tissue and Smears [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Warfarin response genotype panel:-:Pt:Bld/Tiss:-:Molgen [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients